Breast Abstracts RESULTS: No significant differences were found between the 2 groups in terms of demographic characteristics including age, body mass index, smoking status, comorbidities, and previous abdominal surgery (P > 0.05). No significant differences were noted with respect to unilateral versus bilateral donor sites, operative times, and length of hospital stay (P > 0.05). With regard to donor site complications, the wound dehiscence rate was significantly higher for the control group (27.8% versus 6.5; P = 0.023). No differences were noted in terms of infection, seroma formation, hematoma formation, abdominal bulge, or abdominal hernia rates between the 2 groups.
Breast reconstruction completion is the goal of the reconstructive process. Reconstruction completion may be defined as breast mound creation allowing the use of clothing without prosthetics or the stigmata of mastectomy. Creation of the nipple areolar complex (NAC) may also be considered reconstruction completion because many women do not feel like it is their breast again until the NAC in place. In normal body mass index (BMI) patients undergoing breast reconstruction, perioperative complication risk is similar between implant-based and autologous reconstruction. This is not the case in the obese women where breast reconstruction operations are associated with increased risk of perioperative complications. We hypothesize that perioperative complications may affect the eventual completion of reconstruction in the obese women. Our aim is to determine whether reconstruction technique affects the achievement of reconstruction completion in the obese women. An Institutional Review Board-approved retrospective study of consecutive obese women (BMI ≥30) who underwent mastectomy and implant-based or autologous reconstruction over a 10-year period was performed. Patient demographics, comorbidities, oncologic treatments, reconstructive procedures, and their complications were analyzed. Two hundred twenty-five women with 352 breast reconstructions were included with mean follow-up of 27 months. Seventy-four women underwent 111 autologous breast reconstructions and 151 underwent 241 implant reconstructions. Mean age of included women was 52 years. Mean BMI in the autologous group was 33 and 36 in the implant group. There were no differences between groups in terms of age and presence of medical comorbidities. Active tobacco use was noted in 5.4% of the autologous group and 14.5% of implant patients (P = 0.47). Chemotherapy, radiation, and delayed reconstruction timing were more common in the autologous patients compared to the implant group (P = 0.01, P = 0.09, and P < 0.0001, respectively). Minor and major complications occurred more frequently in the implant group compared to the autologous group (P ≤ 0.0001). Breast mounds were completed in >98% of autologous cases compared to 76% of implant cases (P ≤ 0.001). NAC creation was completed in 57% of autologous patients and 33% of implant patients (P = 0.0009). The rate of successfully completing the breast mound and the NAC is higher in the autologous patient group (mound: odds ratio [OR], 3.32; 95% confidence interval [CI], 1.36-5.28; and NAC: OR, 2.7; 95% CI, 1.50-4.69) compared to the implant group. Occurrence of a major complication in the implant group decreases the rate of reconstruction completion (OR, 13.0; 95% CI, 4.9-34.1). Obese women undergoing implant-based breast reconstruction are more likely to have perioperative complications, and 24% of these patients fail to achieve mound completion. Obese women who undergo autologous breast reconstruction are more likely to achieve breast reconstruction completion (both mound creation and completion NAC reconstruction) when compared to obese women who undergo implant-based breast reconstruction.
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BACKGROUND: Breast reconstruction remains an important field in plastic surgery, with most procedures utilizing implants and/or autologous tissue. Few series report on experience with fat grafting as the primary form of breast reconstruction. This study reports a novel method of breast reconstruction using a 3-dimensional absorbable mesh scaffold and subsequent autologous fat grafting (AFG).
METHODS:
A retrospective review was performed for all patients who underwent breast reconstruction using Lotus scaffold and AFG. Postoperative mammogram and magnetic resonance imaging were analyzed, and tissue specimens collected at subsequent procedures were harvested and stained with H&E for histologic evaluation. Finally, compression testing of the scaffold was performed using a tensiometer and digital tracking technology.
RESULTS:
Twenty-two patients underwent reconstruction of 28 breasts using Lotus scaffold and AFG between February 2015 and February 2018. Average follow-up was 19 months. All patients were satisfied with final breast shape and size. Mean patient age was 60.5 years, and average body mass index was 28. Patients required on average 2 fat grafting sessions to achieve a successful result (range, 1-4). Postoperative mammogram and magnetic resonance imaging revealed robust adipose tissue in the breast with a slowly resorbing mesh and no oil cysts or calcifications. Histologic evaluated revealed no capsule formation with ingrowth of fat tissue around the scaffold. Compression testing revealed that the Lotus scaffold is a compliant construct with a high resilience profile.
CONCLUSIONS:
The Lotus scaffold with AFG is a viable method for breast reconstruction, giving the patient an autologous reconstruction with less morbidity than free tissue transfer.
